Cannabis Bioscience International Holdings, Inc.
CBIH • Drug Manufacturers - Specialty & Generic
$0.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Feb 28, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.74M
Growth
-35.4%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.03Negative growth trendWeak profitability
Financial data as of: Feb 28, 2026, 12:00 AM UTCLast earnings update: Feb 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Shares Out11.63B
Market Cap$1.74M
Enterprise Value$2.15M
52W Range0.00 - 0.00
Beta1.50
P/E-3.38
P/S14.11
P/B-1.19
P/FCF-7.15
EV/Sales17.39
Price$0.00
Change0.00%
Shares Out11.63B
Market Cap$1.74M
Enterprise Value$2.15M
52W Range0.00 - 0.00
Beta1.50
P/E-3.38
P/S14.11
P/B-1.19
P/FCF-7.15
EV/Sales17.39
EV/EBITDA-7.08
EV/FCF-8.82
Earnings Yield-29.55%
FCF Yield-13.98%
Dividend Yield0.00%
Gross Margin86.76%
Oper. Margin-139.05%
Profit Margin-181.12%
Debt/Eq-0.36
Current Ratio0.03
Quick Ratio0.03
Revenue 5Y-35.38%
Volume2.27M
Avg Volume13.13M
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Weak liquidity · 0.03Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Financial Health
Score4 / 20
Debt / Equity: -0.36
Current Ratio: 0.03
Quick Ratio: 0.03
Status: HighRisk
Warnings
- Weak Liquidity
- Weak quick ratio
🧾
No insider activity
No recent insider transactions available.